Invus Public Equities, L.P. reports

Company location: New York, NY

Invus Public Equities, L.P. has filed 88 SEC EDGAR filings since 30 Sep 2005

Filter by type:
SC13D
SC13G

SEC filing history

Showing 1-22 of 22 matching filings.

Per page

25

Current page

1

SC 13G/A

SC 13G/A

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SC 13G

Filing date: 13 Nov 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A

Filing date: 12 Feb 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SC 13G filing

Filing date: 09 Feb 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SCHEDULE 13G

Filing date: 06 Jul 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

FURIEX PHARMACEUTICALS, INC. NO. 5

Filing date: 14 Feb 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AUXILIUM PHARMACEUTICALS, INC. NO. 4

Filing date: 14 Feb 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SCHEDULE 13G

Filing date: 27 Aug 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A

Filing date: 19 Feb 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A

Filing date: 31 Jan 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A

Filing date: 31 Jan 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A - FURIEX PHARMACEUTICALS, INC.

Filing date: 10 Apr 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A - AUXILIUM PHARMACEUTICALS, INC.

Filing date: 10 Apr 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 13 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 13 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 13 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 13 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 13 Feb 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SC 13G filing

Filing date: 05 Aug 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SC 13G filing

Filing date: 26 Apr 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .